首页 > 市场调查报告书 > 医疗设备

伤口护理

防黏剂市场规模、份额及成长分析（按产品、应用、配方及地区划分）－产业预测，2026-2033年

市场调查报告书

商品编码

1895534

防黏剂市场规模、份额及成长分析（按产品、应用、配方及地区划分）－产业预测，2026-2033年

Adhesion Barrier Market Size, Share, and Growth Analysis, By Product (Synthetic Adhesion Barriers, Natural Adhesion Barriers ), By Application (Gynecological Surgeries, Cardiovascular Surgeries), By Formulation, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，防黏剂市场规模将达到 7.3 亿美元，到 2025 年将达到 7.8 亿美元，到 2033 年将达到 13.6 亿美元，预测期（2026-2033 年）的复合年增长率为 7.2%。

由于外科手术和运动伤害的激增，以及全球医疗费用支出的不断增长，防沾黏屏障市场预计将迎来显着成长。整形外科和心血管手术数量的增加预计将推动对防沾黏屏障的需求。此外，运动伤害的增加也促使人们需要进行外科手术。人口成长和医疗技术的进步预计也将推动市场扩张，这将带动新兴经济体对医疗设备的需求。可支配收入的增加将提高个人用于医疗保健的经济能力，从而推动防粘连屏障等先进产品的普及。然而，高昂的手术费用、潜在的副作用以及严格的法规结构等挑战可能会阻碍市场发展。

防黏剂市场細項分析

防沾黏屏障市场按产品、应用、配方和地区细分。依产品划分，可分为合成防沾黏屏障（玻尿酸、再生纤维素、聚乙二醇及其他合成防沾黏屏障）及天然防沾黏屏障（胶原蛋白、纤维蛋白）。依应用划分，可分为一般外科/腹部外科、妇科外科、心血管外科、整形外科外科、神经外科及其他外科。依配方划分，可分为薄膜、液体和凝胶。依地区划分，可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

防黏剂市场驱动因素

外科手术在包括一般外科、腹部外科、妇科手术、心血管外科、整形外科和神经外科在内的各个专科领域的扩展，是推动防沾黏屏障市场发展的主要因素。随着这些手术频率的持续增长，对能够最大限度降低术后併发症风险并预防沾黏形成的高效防沾黏屏障的需求也日益增长。人们对防沾黏屏障在改善手术效果方面的益处认识不断提高，推动了其应用，进而促进了市场成长，并凸显了其在现代外科手术中的重要性。

防黏剂市场限制因素

手术和防沾黏剂相关的高昂费用对市场扩张构成了显着挑战。这些经济限制可能会阻碍防沾黏剂的广泛应用，尤其是在医疗预算有限、保险覆盖率较窄的地区。因此，产品和手术的高成本构成了一道屏障，抑制了其在各种医疗机构中的普及和推广，最终可能影响患者的治疗效果和防粘连策略的整体有效性。对于希望拓展防黏连剂市场的相关人员而言，这个经济因素仍然是关键考虑因素。

防黏剂市场趋势

受以病患安全和创新解决方案为核心的显着趋势驱动，防沾黏屏障市场正经历显着成长。其中一个关键趋势是，消费者越来越倾向选择生物可吸收防沾黏屏障。这类屏障可在体内自然降解，消除了永久性解决方案的风险，并减少了后续手术的必要性。这一转变反映了人们越来越重视改善患者预后和最大限度减少併发症。此外，产品创新也备受关注，製造商投入大量资金进行研发，以开发先进的配方。这些创新旨在提高生物相容性、延长疗效和改善易用性，从而推动市场扩张并满足不断变化的医疗需求。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Baxter International Inc.（United States）
Anika Therapeutics, Inc.（United States）
Sanofi SA（France）
Medtronic plc（Ireland）
Integra LifeSciences Corporation（United States）
Atrium Medical Corporation（Getinge AB）（United States）
FzioMed, Inc.（United States）
MAST Biosurgery AG（Switzerland）
Terumo Corporation（Japan）
Johnson & Johnson（United States）
Becton, Dickinson and Company（United States）
B. Braun Melsungen AG（Germany）
Ferring Pharmaceuticals（Switzerland）
Adhesion Barrier Company（United States）
Fidia Farmaceutici SpA（Italy）
Innocoll Holdings PLC（Ireland）
Biom'Up SAS（Zimmer Biomet Holdings, Inc.）（France）
Aziyo Biologics, Inc.（United States）

结论与建议

简介目录

Product Code: SQMIG15B2076

Adhesion Barrier Market size was valued at USD 0.73 Billion in 2024 and is poised to grow from USD 0.78 Billion in 2025 to USD 1.36 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The adhesion barrier market is poised for significant growth driven by a surge in surgical procedures and sports-related injuries, alongside escalating global healthcare expenditure. The increasing volume of orthopedic surgeries and cardiovascular operations is set to elevate the demand for adhesion barriers. Additionally, rising sports injuries contribute to the necessity of surgical interventions. Emerging economies are also expected to bolster market expansion as population growth and healthcare advancements lead to a higher demand for medical devices. As disposable incomes rise, individuals tend to allocate more funds towards medical care, enhancing adoption rates of cutting-edge products like adhesion barriers. However, challenges such as high surgical costs, potential side effects, and stringent regulatory frameworks may hinder market progress.

Top-down and bottom-up approaches were used to estimate and validate the size of the Adhesion Barrier market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Adhesion Barrier Market Segments Analysis

Adhesion Barrier Market is segmented by Product, Application, Formulation and region. Based on Product, the market is segmented into Synthetic Adhesion Barriers, (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Other Synthetic Adhesion Barriers) and Natural Adhesion Barriers (Collagen and Fibrin), Based on Application, the market is segmented into General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, and Others. Based on Formulation, the market is segmented into Film, Liquid, and Gel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Adhesion Barrier Market

The expansion of surgical procedures across various specialties such as general and abdominal surgeries, gynecological interventions, cardiovascular operations, orthopedic treatments, and neurological surgeries is a key catalyst for the adhesion barrier market. As the frequency of these surgical operations continues to rise, there is an escalating need for efficient adhesion barriers that can help minimize the risk of postoperative complications and prevent the formation of adhesions. This increasing awareness of the benefits of adhesion barriers in promoting better surgical outcomes drives their adoption, thereby propelling market growth and emphasizing their importance in modern surgical practices.

Restraints in the Adhesion Barrier Market

The substantial expenses linked to surgical procedures and adhesion barriers present notable challenges for market expansion. These financial constraints can deter the widespread adoption of adhesion barriers, particularly in areas where healthcare budgets are restricted or insurance coverage is limited. As a result, the high costs associated with both the products and the procedures may create barriers that hinder growth and accessibility in various healthcare settings, ultimately affecting patient outcomes and the overall effectiveness of adhesion prevention strategies. This economic factor remains a critical consideration for stakeholders aiming to enhance the market for adhesion barriers.

Market Trends of the Adhesion Barrier Market

The Adhesion Barrier market is experiencing significant growth fueled by notable trends that prioritize patient safety and innovative solutions. A key trend is the rising preference for bioresorbable adhesion barriers, which naturally degrade within the body, thereby eliminating the risks associated with permanent solutions and reducing the need for subsequent surgeries. This shift reflects a growing commitment to enhancing patient outcomes and minimizing complications. Additionally, there is a strong emphasis on product innovation, with manufacturers investing heavily in research and development to create advanced formulations. These innovations focus on enhancing biocompatibility, prolonging efficacy, and improving usability, driving market expansion and meeting evolving medical needs.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
- PESTEL Analysis
Market Attractiveness Index
Pricing Analysis

Global Adhesion Barrier Market Size by Product & CAGR (2026-2033)

Market Overview
Synthetic Adhesion Barriers
- Hyaluronic Acid
- Regenerated Cellulose
- Polyethylene Glycol
- Other
Natural Adhesion Barriers
- Collagen
- Fibrin

Global Adhesion Barrier Market Size by Application & CAGR (2026-2033)

Market Overview
General/Abdominal Surgeries
Gynecological Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Neurological Surgeries
Other

Global Adhesion Barrier Market Size by Formulation & CAGR (2026-2033)

Market Overview
Film
Liquid
Gel

Global Adhesion Barrier Market Size & CAGR (2026-2033)

North America, (Product, Application, Formulation)
- US
- Canada
Europe, (Product, Application, Formulation)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Application, Formulation)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Application, Formulation)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Application, Formulation)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anika Therapeutics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atrium Medical Corporation (Getinge AB) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FzioMed, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MAST Biosurgery AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adhesion Barrier Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fidia Farmaceutici S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innocoll Holdings PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biom'Up SAS (Zimmer Biomet Holdings, Inc.) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aziyo Biologics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments